Gadoversetamide
Paramagnetic Contrast Agent — VARIOUS
Also known as: optimark
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Gadoversetamide is a drug in the Paramagnetic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1999. Its mechanism of action is classified as Magnetic Resonance Contrast Activity. Recorded indications include Magnetic resonance imaging.
- Drug class: Paramagnetic Contrast Agent.
- Mechanism of action: Magnetic Resonance Contrast Activity.
- Indications: Magnetic resonance imaging.
- ATC code: V08CA06 (Paramagnetic contrast media).
- Molecular formula: C20H34GdN5O10; molecular weight 661.77 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Magnetic resonance imaging
Mechanism & targets
| Mechanism of action (MoA) | Magnetic Resonance Contrast Activity |
|---|---|
| Established pharmacologic class | Paramagnetic Contrast Agent |
Regulatory approvals (2)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2007-07-23 | EMA | — | — | |
| 1999-12-08 | FDA | — | LIEBEL-FLARSHEIM |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08CA06 | VARIOUS › CONTRAST MEDIA › MAGNETIC RESONANCE IMAGING CONTRAST MEDIA › Paramagnetic contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Gadolinium deposition disease | 122.6 |
| Nephrogenic systemic fibrosis | 114.1 |
Chemical structure
| Molecular formula | C20H34GdN5O10 |
|---|---|
| Molecular weight | 661.77 g/mol |
| CAS number | 131069-91-5 |
| InChIKey | — |
| PubChem CID | 444013 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Gadoversetamide used for?
DrugCentral lists the following indications for Gadoversetamide: Magnetic resonance imaging.
How does Gadoversetamide work?
Gadoversetamide is classified as Magnetic Resonance Contrast Activity.
When was Gadoversetamide first approved?
Gadoversetamide was first approved by the FDA in 1999.
What drug class does Gadoversetamide belong to?
Gadoversetamide is in the Paramagnetic Contrast Agent class.
What is the chemical formula of Gadoversetamide?
Gadoversetamide has the molecular formula C20H34GdN5O10 and a molecular weight of 661.77 g/mol.
Browse: all drugs starting with G · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4147 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200457 — compound record and bioactivity
- PubChem CID 444013 — chemical identifiers
- DrugBank DB00538 — drug record
- FDA UNII RLM74T3Z9D — substance identity
- DailyMed: FDA labels for Gadoversetamide — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.